Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial.

Yan, Wenting; Wu, Xiujuan; Wang, Shushu; He, Cheng; Zhong, Ling; Tang, Peng; Ren, Lin; Zhang, Ting; Qi, Xiaowei; Zhang, Yi

Yan, Wenting; Wu, Xiujuan; Wang, Shushu; He, Cheng; Zhong, Ling; Tang, Peng; Ren, Lin; Zhang, Ting; Qi, Xiaowei; Zhang, Yi.

Afiliación

Yan W; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Wu X; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Wang S; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
He C; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Zhong L; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Tang P; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Ren L; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Zhang T; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Qi X; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Gaotanyan Street 29, Chongqing 400038, China.
Zhang Y; Department of Breast and Thyroid Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Gaotanyan Street 29, Chongqing 400038, China.

Ther Adv Med Oncol ; 14: 17588359221107111, 2022.

Article en En | MEDLINE | ID: mdl-35769355

Palabras clave

lobaplatin; neoadjuvant chemotherapy; platinum; prognosis; triple-negative breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google